Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway

<div>Berberine decreases the hepatic lipid accumulation. (a) Control group, (b) model (DM) group, (c) glimepiride group, (d) metformin group, (e) glimepiride+metformin group, (f) berberine (150 mg/kg) group, and (g) berberine (300 mg/kg) group. Scale bars, 50 <i>μ</i>m.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway 

Figure 2 | Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway 